Interaction of p53 with Mdm2 and azurin as studied by atomic force spectroscopy

Journal of Molecular Recognition

Volumn 23, Issue 4, 2010, Pages 343-351

  Funari, Gloria ^a   Domenici, Fabio ^a   Nardinocchi, Lavinia ^b,c   Puca, Rosa ^b,c   D'Orazi, Gabriella ^b,c   Bizzarri, Anna Rita ^a   Cannistraro, Salvatore ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

AFM; Azurin; Force spectroscopy; Mdm2; Molecular interaction; p53

Indexed keywords

AZURIN; MDM2 PROTEIN, HUMAN; PROTEIN MDM2; PROTEIN P53;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING;

AZURIN; HUMANS; MICROSCOPY, ATOMIC FORCE; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

BACTERIA (MICROORGANISMS);

EID: 77954735682     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.999     Document Type: Article

References (61)

1. Apiyo D, Wittung-Stafshede P. 2005. Unique complex between bacterial azurin and tumour-suppressor protein p53. Biochem. Biophys. Res. Commun. 332: 965-968.
2. Baumgartner W, Hinterdorfer P, Ness W, Raab A, Vestweber D, Schindler H, Drenckhahn D. 2000. Cadherin interaction probed by atomic force microscopy. Proc. Natl Acad. Sci. USA 97: 4005-4010.
3. Bell GI. 1978. Models for the specific adhesion of cells to cells. Science 200: 618-627.
4. Bell S, Klein C, Muller L, Hansen S, Buchner J. 2002. Contains large unstructured regions in its native state. J. Mol. Biol. 322: 917-927.
5. Bonanni B, Bizzarri AR, Cannistraro S. 2006. Optimized biorecognition of cytochrome c 551 and azurin immobilized on thiol-terminated monolayers assembled on Au (111) substrates. J. Phys. Chem. B 110: 14574-14580.
6. Bonanni B, Kamruzzahan SM, Bizzarri AR, Rankl C, Gruber HJ, Hinterdorfer P, Cannistraro S. 2005. Single molecule recognition between cytochrome c 551 and gold-immobilized azurin by force spectroscopy. Biophys. J. 89: 2783-2791.
7. Bossi G, Sacchi A. 2007. Restoration of wild-type p53 function in human cancer: relevance for tumour therapy. Head & Neck 29: 272-284.
8. Chan RY, Mak MC, Fung TK, Lan A, Sin WY, Poon RY. 2006. Ubiquitination of p53 at multiple sites in the DBD-binding domain. Mol. Cancer Res. 1: 15-25.
9. Chen J, Marechal V, Levine AJ. 1993. Mapping of the p53 and Mdm2 interaction domains. Mol. Cell. Biol. 13: 4107-4114.
10. Chi SW, Lee SH, Kim DH, Ahn MJ, Kim JS, Woo JY, Torizawa T, Kainosho M, Han KH. 2005. Structural details on Mdm2-p53 interaction. J. Biol. Chem. 18: 38795-38802.
11. Clegg HV, Itahana K, Zhang Y. 2008. Unlocking the Mdm2/p53 loop. Cell Cycle 7: 1-6.
12. Dawson R, Muller L, Dehner A, Klein C, Kessler H, Buchner J. 2003. The N-terminal domain of p53 is natively unfolded. J. Mol. Biol. 332: 1131-1141.
13. De Grandis V, Bizzarri AR, Cannistraro S. 2007. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin. J. Mol. Recognit. 20: 215-226.
14. Ebner A, Hinterdorfer P, Gruber HJ. 2007. Comparison of different aminofunctionalization strategies for attachment of single antibodies to AFM cantilevers. Ultramicroscopy 107: 922-927.
15. Evans E, Ritchie K. 1997. Dynamic strength of molecular adhesion bonds. Biophys. J. 72: 1541-1555.
16. Freedman DA, Wu L, Levine AJ. 1999. Functions of the Mdm2 oncoprotein. Cell. Mol. Life Sci. 55: 96-107.
17. Friddle RW, Sulchek TA, Albrecht H, De Nardo SJ, Noy A. 2007. Counting and breaking individual biological bonds: Force spectroscopy of tethered ligand-receptor pairs. Current Nanosci. 3: 41-48.
18. Friedsam C, Wehle AK, Kuhner F, Gaub HE. 2003. Dynamic single molecule force spectroscopy: bond rupture analysis with variable spacer length. J. Phys. Cond. Matt. 15: S1709-S1723.
19. Fuhrmann A, Anselmetti D, Ros R. 2008. Refined procedure of evaluating experimental single-molecule force spectroscopy data. Phys. Rev. E77 031912: 1-10.
20. Hanley W, McCarty O, Jadhav S, Tseng Y, Wirtz D, Konstantopoulos K. 2003. Single molecule characterization of P-selectin/Ligand binding. J. Biol. Chem. 278: 10556-10561.
21. Harris SL, Levine AJ. 2005. The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908.
22. Haupt Y, Maya R, Kazaz A, Oren M. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
23. Hinterdorfer P, Baumgartner W, Gruber HJ, Schilcher K, Schindler H. 1996. Detection and localization of individual antibody-antigen recognition events by atomic force microscopy. Proc. Natl Acad. Sci. USA 93: 3477-3481.
24. Hinterdorfer P, Dufrêne YF. 2006. Detection and localization of single molecular recognition events using atomic force microscopy. Nature Meth. 3: 347-355.
25. Hinterdorfer P, Kienberger F, Raab A, Gruber HJ, Baumgartner W, Kada G, Riener C, Wielert-Badt S, Borken C, Schindler H. 2000. Poly (Ethylene Glycol): an ideal spacer for molecular recognition force microscopy/ spectroscopy. Single Mol. 1: 99-103.
26. Honda R, Tanaka H, Yasuda H. 1997. Oncoprotein Mdm2 is an ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27.
27. Hutter JL, Bechhoefer J. 1993. Calibration of atomic-force microscope tips. Rev. Sci. Instrum. 64: 1868-1873.
28. Janshoff A, Steinem C. 2001. Energy landscapes of ligand-receptor couples probed by dynamic force spectroscopy. ChemPhysChem 2: 577-579.
29. Kienberger F, Kada G, Gruber HJ, Pastushenko V, Riener C, Trieb M, Knaus HG, Schindler H, Hinterdorfer P. 2000a. Recognition force spectroscopy studies of the NTA-His6 bond. Single Mol. 1: 59-65.
30. Kienberger F, Pastushenko VP, Kada G, Gruber HJ, Riener C, Schindler H, Hinterdorfer P. 2000b. Static and dynamical properties of single poly (ethylene glycol) molecules investigated by force spectroscopy. Single Mol. 1: 123-128.
31. Ko LJ, Prives C. 1996. p53: puzzle and paradigm. Genes Develop. 10: 1054-1072.
32. Kubbutat MH, Jones SN, Vousden KH. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
33. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP. 1996. Structure of the Mdm2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
34. Lai Z, Auger KR, Manubay CM, Copeland RA. 2000. Thermodynamics of p53 binding to hdm2 (1-126): effects of phosphorylation and p53 peptide length. Arch. Biochem. Biophys. 381: 278-284.
35. Lavin MF, Gueven N. 2006. The complexity of p53 stabilization and activation. Cell Death Diff. 13: 941-950.
36. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
37. Lim TS, Vedula SR, Kausalya PJ, Hunziker W, Lim CT. 2008. Singlemolecular-level study of claudin-1-mediated adhesion. Langmuir 24: 490-495.
38. Lu S, Ye Z, Zhu C, Long M. 2006. Quantifying the effects of contact duration, loading rate, and approach velocity on P-selectin-PSGL-1 interactions using AFM. Polymer 47: 2539-2547.
39. Marshall BT, Sarangapani KK, Lou J, McEver RP, Zhu C. 2005. Force history dependence of receptor-ligand dissociation. Biophys. J. 88: 1458-1466.
40. Merkel R. 2001. Force spectroscopy on single passive biomolecules and single biomolecular bonds. Physics Reports 346: 343-385.
41. Momand J, Zanbetti GP, Olson DC, George D, Levine AJ. 1992. The Mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
42. Oren M. 2003. Decision making by p53: life, death and cancer. Cell Death Diff. 10: 431-442.
43. Panorchan P, Thompson MS, Davis KJ, Tseng Y, Konstantopoulos K, Wirtz D. 2006. Single molecule analysis of cadherin-mediated cell-cell adhesion. J. Cell Sci. 119: 66-74.
44. Ratto TV, Langry KC, Rudd RE, Balhorn RL, Allen MJ, McElfresh MW. 2004. Force spectroscopy of the double-tethered concanavalin A mannose bond. Biophys. J. 86: 2430-2437.
45. Rief M, Grubmuller H. 2002. Force spectroscopy of single biomolecules. ChemPhysChem 3: 255-261.
46. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. 1998. Nucleocytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 2: 554-564.
47. Schon O, Friedler A, Bycroft M, Freund SMV, Fersht AR. 2002. Molecular mechanism of the interaction between Mdm2 and p53. J. Mol. Biol. 323: 491-501.
48. Sulchek TA, Friddle RW, Langry K, Lau EY, Albrecht H, Ratto TV, DeNardo SJ, Colvin ME, Noy A. 2005. Dynamic force spectroscopy of parallel individual Mucin-1-antibody bonds. Proc. Natl Acad. Sci. USA 102: 16638-16643.
49. Sulchek T, Friddle RW, Noy A. 2006. Strength of multiple parallel biological bonds. Biophys. J. 90: 4686-4691.
50. Taranta M, Bizzarri AR, Cannistraro S. 2008a. Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy. J. Mol. Recognit. 21: 63-70.
51. Taranta M, Bizzarri AR, Cannistraro S. 2008b. Modelling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin. J. Mol. Recognit. 22: 215-222.
52. Thormann E, Hansen PL, Simonsen AC, Mouritsen OG. 2006. Dynamic force spectroscopy on soft molecular systems: improved analysis of unbinding spectra with varying the linker compliance. Coll. Surf. B: Bioint. 53: 149-156.
53. Vassilev LT. 2007. Mdm2 inhibitors for cancer therapy. Trends Mol. Med. 13: 23-31.
54. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. 2004. In vivo activation of the p53 pathway by small-molecule antagonists of Mdm2. Science 303: 844-848.
55. Vijgenbbom E, Busch JE, Canters GW. 1997. In vivo studies disprove an obligatory role of azurin in denitrification in Pseudomonas Aeruginosa and show that azurin expression is under control of RpoS and ANR. Microbiology 143: 2853-2863.
56. Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
57. Wielert-Badt S, Hinterdorfer P, Gruber H, Lin JT, Badt D, Wimmer B, Schindler H, Kinne RK., 2002. Single molecule recognition of protein binding epitopes in brush border membranes by force microscopy. Biophys. J. 82: 2767-2774.
58. Wiman KG. 2006. Strategies for therapeutic targeting of the p53 pathway in cancer. Cell Death Diff. 13: 921-926.
59. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM. 2002. Bacterial redox protein azurin, tumour suppressor protein p53, and regression of cancer. Proc. Natl Acad. Sci. USA 99: 14098-14103.
60. Zhang X, Wojcikiewicz E, Moy VT. 2002. Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. Biophys. J. 83: 2270-2279.
61. Zlatanova J, Lindsay SM, Leuba SH. 2000. Single molecule force spectroscopy in biology using the atomic force microscope. Progress Biophys. Mol. Biol. 74: 37-61.